Hydroxyapatite Market- By Type , By Application , By Geography - Global Opportunity Analysis & Industry Forecast, 2024-2030

Hydroxyapatite Market Overview

Hydroxyapatite Market size is forecast to reach $2.9 billion by 2030, after growing at a CAGR of 6% during 2024-2030. Increasing demand from end-use industries such as healthcare drives global market growth for hydroxyapatite. Additionally, in orthopedic procedures hydroxyapatite is used as a bone replacement. The rise in orthopedic surgery affordability is expected to fuel global market growth. In addition, ongoing research and development activities aimed at increasing the applicability of hydroxyapatite in the medical industry are anticipated to drive global market growth.

Nanotechnology is significantly influencing the hydroxyapatite market by enhancing its applications and performance. Nanoscale hydroxyapatite particles exhibit improved bioactivity, mechanical properties, and surface area compared to their bulk counterparts. These advancements allow for better integration with natural bone and promote faster healing and regeneration. Researchers are developing hydroxyapatite nanoparticles for targeted drug delivery systems and advanced dental treatments, leading to increased effectiveness and reduced side effects. This trend is expected to drive the market as nanotechnology-based products continue to receive regulatory approvals and gain acceptance in medical and dental practices.

The hydroxyapatite market is witnessing a surge in demand within the dental industry. Hydroxyapatite is extensively used in dental implants, toothpastes, and oral care products due to its ability to remineralize enamel and improve overall dental health. Innovations in dental materials have led to the development of hydroxyapatite-based composite resins and coatings that enhance the durability and aesthetics of dental restorations. Additionally, the growing awareness of oral health and the rising incidence of dental diseases globally are propelling the adoption of hydroxyapatite in preventive and restorative dental treatments, driving market growth in this sector.

Report Coverage

The report: “Hydroxyapatite Market – Forecast (2024-2030)”, by IndustryARC, covers an in-depth analysis of the following segments of the Hydroxyapatite Industry. 

By Type: Nano-Sized, Micro-Sized, and Greater Than Micrometer.

By Application: Orthopedic, Dental Care, Plastic Surgery, and Others.

By Geography: North America, South America, Europe, APAC, and RoW.

Key Takeaways

• Strict international healthcare regulations for use of hydroxyapatite are anticipated to curb the growth of the global demand for hydroxyapatite. Nevertheless, it is expected that ease of availability of raw materials and increasing healthcare industry will provide lucrative opportunities for the growth of the global market for hydroxyapatite.
• The COVID-19 pandemic affects health care networks around the world. The rapidly rising demand for health care services and health care staff is threatening to leave some health systems overstretched and incapable of functioning effectively. This factor is affecting the healthcare industry. 

By Type - Segment Analysis

The market is segmented into type which includes nano-sized, micro-sized, and greater than micrometers. In 2023, the micro-sized segment represented the biggest share of the hydroxyapatite market. The primary use of micro-sized hydroxyapatite is as an alternative to allogeneic and xenogeneic bone grafts. It's also used to cover voids in bones and teeth as a bone filler. The micro-sized hydroxyapatite is used for guided delivery of genes and proteins to the target tissues in the pharmaceutical applications. Micro-sized hydroxyapatite is also used as an implant and screw-coating.

By Application - Segment Analysis

The Hydroxyapatite market was segmented on application basis into orthopedic, dental care, plastic surgery and others. In 2023 the Hydroxyapatite market was led by the orthopedic group. During the forecast period this market segment is also expected to lead the industry. According to World Health Organization, approximately 1.71 billion people have musculoskeletal conditions worldwide in 2022. Hydroxyapatite is used as implant padding, bone grafts, and bone fillers. Hydroxyapatite is used as an alternative to allogeneic and xenogeneic bone grafts due to its bioactivity, resulting in the required reduced healing time. The aging global population and increasing demand for bioactive ceramics are driving demand for hydroxyapatite in orthopedic applications in bone replacement surgeries.

Geography - Segment Analysis

In 2023, North America is accounted for the largest share of the hydroxyapatite market due to highest investment for healthcare infrastructure in the region. According to World Health Organization in 2022, the total number of orthopedic procedures performed in the United States alone was 18,577,953. In addition, Asia Pacific hydroxyapatite market is anticipated to expand at a highest CAGR during the forecast period. Owning to the growing demand for hydroxyapatite from countries such as China, Japan, and South Korea is driving the growth of the Asia Pacific hydroxyapatite market. Moreover, the aging population, increasing disposable income of the middle-class population, and growing awareness among masses about the advantages of dental bone grafting and bone grafting over traditional treatments provide a huge growth opportunity for the manufacturers of hydroxyapatite in the Asia Pacific region.

For more details on this report - Request for Sample

Drivers – Hydroxyapatite Market

Growing demand of medical implants in healthcare industry.

Medical implants are artificial devices which replace damaged or missing biological components. Implants help administer medicine, control body processes, and also provide assistance in various applications for organs and tissues (such as dental, orthopedic, and cardiovascular). The demand for medical implants is driven by the rising healthcare needs of the geriatric population, advancements in medical technology and the increasing prevalence of chronic diseases such as osteoarthritis, cardiovascular diseases, neuropathic diseases and congenital disorders. According to World Health Organization, in 2022 oral diseases affect close to 3.5 billion people worldwide, with 3 out of 4 people affected living in middle-income countries.

Challenges – Hydroxyapatite Market

The growing popularity of bioresorbable composites and lack in performance benchmarking.

The bioactive ceramics (Hydroxyapatite and bioglass) are used to replace various features of the natural bone structures. While Hydroxyapatite is highly biocompatible, it has poor mechanical properties such as low toughness of fracture which limits its load-bearing ability. This is expected to increase the adoption of alternative compounds, such as bioresorbable and bioinert ceramic materials over, particularly in applications where good load-bearing capabilities are crucial. The growing usage of alternative material have become a greater challenge which is constraining the growth of the market.

Market Landscape

Technology launches, acquisitions and R&D activities are key strategies adopted by players in the Hydroxyapatite market. Hydroxyapatite Market top 10 companies are CAM Bioceramics, Berkeley Advanced Biomaterials, SigmaGraft Inc. Biomaterials, Fluidinova, Taihei Chemical Industrial Co. Ltd., SofSera, APS Material, Zimmer Biomet, and APS Materials. Other players in the value chain analysis (and not included in the report) include CG Bio Inc., Fluidinova, Sigmagraft, and Granulab (M) Sdn Bhd., among others.

Acquisitions/Technology Launches:

• In February 2022, TSAML an indirect wholly owned subsidiary of Tata Steel Limited, has executed a Share Purchase cum Shareholders’ Agreement for acquisition of 90% equity stake in Ceramat Private Limited to focus on producing Hydroxyapatite, a calcium phosphate-based ceramic used as bone replacement. 

For more Chemicals and materils related reports, please click here